Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
Janux commences Phase Ib studies in trial for prostate cancer treatment
Clinical Trials Arena
Tue, 05/6/25 - 10:31 am
Janux Therapeutics
JANX007
clinical trials
prostate cancer
metastatic castration-resistant prostate cancer
AstraZeneca’s Truqap fails in another Phase III trial
Clinical Trials Arena
Wed, 04/30/25 - 11:25 am
AstraZeneca
Truqap
clinical trials
prostate cancer
metastatic castration-resistant prostate cancer
FDA broadens use of Novartis’ radiopharma drug Pluvicto
BioPharma Dive
Sun, 03/30/25 - 10:36 pm
Novartis
Pluvicto
FDA
prostate cancer
radiopharmaceuticals
Actinium Pharmaceuticals unveils novel prostate cancer therapy
Investing.com
Thu, 03/27/25 - 11:14 am
Actinium Pharmaceuticals
radiotherapy
ATNM-400
prostate cancer
MacroGenics axes ADC drug following Phase II failure in prostate cancer
Clinical Trials Arena
Tue, 03/25/25 - 10:27 am
Macrogenics
clinical trials
prostate cancer
vobra duo
Blue Earth’s radioligand therapy achieves high tumour radiation absorption
Clinical Trials Arena
Fri, 03/14/25 - 11:15 am
Blue Earth Therapeutics
Lutetium rhPSMA-10.1
radioligand
prostate cancer
Zantac Lawsuit: Illinois Jury Rules in Favor of Boehringer Ingelheim
Lawyer Monthly
Tue, 02/25/25 - 10:41 pm
Boehringer Ingelheim
Zantac
Illinois
prostate cancer
legal
Pfizer’s Talzenna gains 14-months OS lead over mCRPC SoC
Clinical Trials Arena
Tue, 02/18/25 - 09:49 am
Pfizer
prostate cancer
clinical trials
Talzenna
Xtandi
Pfizer outlines Talzenna's survival benefit in bid for broad prostate cancer approval
Fierce Pharma
Thu, 02/13/25 - 11:43 am
Pfizer
Talzenna
prostate cancer
Leaked Conference Article Shows Pfizer’s Positive Phase I Prostate Cancer Data
BioSpace
Tue, 02/11/25 - 11:41 am
Pfizer
ASCO
Mevrometostat
prostate cancer
After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win
Pharma Voice
Thu, 01/9/25 - 11:09 am
Candel Therapeutics
cancer immunotherapy
prostate cancer
Candel Therapeutics stock up 172% after Phase III prostate cancer success
Clinical Trials Arena
Wed, 12/11/24 - 11:19 am
Candel Therapeutics
clinical trials
prostate cancer
CAN-2409
Lava burnt by blood cancer drug's performance in phase 1, pivots to preclinical backup
Fierce Biotech
Tue, 12/10/24 - 11:32 am
Lava Therapeutics
clinical trials
LAVA-1207
prostate cancer
blood cancer
Janux impresses Wall Street with new prostate cancer drug results
BioPharma Dive
Tue, 12/3/24 - 11:42 pm
Janux Therapeutics
prostate cancer
clinical trials
JANX007
Bayer expands indications for Nubeqa with new drug application
Clinical Trials Arena
Thu, 11/21/24 - 11:39 am
Bayer
Nubeqa
prostate cancer
FDA
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tue, 11/19/24 - 11:22 am
prostate cancer
clinical trials
Candel Therapeutics
ProstAtak
JNJ
Akeega
Pfizer
Mevrometostat
MacroGenics pauses work on vobra duo ADC pending mature survival data
Fierce Biotech
Wed, 11/6/24 - 11:39 am
Macrogenics
vobra duo
antibody drug conjugate
prostate cancer
Essa abandons sole clinical-stage drug after falling short against Xtandi in phase 2 trial
Fierce Biotech
Sun, 11/3/24 - 10:17 pm
Essa Pharma
prostate cancer
masofaniten
Xtandi
Astellas
Pfizer
AngioDynamics launches long-term study of NanoKnife for prostate cancer
Clinical Trials Arena
Thu, 10/24/24 - 09:52 am
AngioDynamics
prostate cancer
NanoKnife
clinical trials
medtehc
Pfizer's cancer drug combo improves overall survival in late-stage study
Reuters
Thu, 10/10/24 - 09:59 am
Pfizer
Talzenna
Xtandi
prostate cancer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »